DOLPHIN-VIVO: an observational study looking at diagnosing lymphoma with a less invasive method
This study does not involve any treatment. The researchers are testing a new probe that would be able to diagnose lymphoma without the need for a biopsy.
You can share the following ClinicalTrials.gov Identifier with your medical team so they can find out more about the trial: NCT04162431
Trial aim and background
The aim of this trial is to demonstrate the new probe devise as being effective in diagnosing lymphoma.
A lymphoma diagnosis often involves the removal and biopsy of one or more lymph nodes. Many of these diagnostic procedures show that no cancer is present, meaning that a lot of the procedures are unnecessary.
Investigators in the DOLPHIN-VIVO study have shown that it is possible to tell the difference between healthy cells and cancerous cells by looking at the light emitted by tissue when a laser is shone on it. They have designed a probe that goes through a fine needle to the lymph node, guided by an ultrasound scan.
Who can enter
Patients undergoing biopsy or excision of lymph nodes as part of their routine clinical care within Gloucestershire Hospitals NHS Foundation Trust may be eligible for this trial.
Locations
Recruitment is taking place at the Gloucestershire Hospitals NHS Foundation Trust, Gloucester
Further information
More information about the criteria you must meet in order to take part in the trial and where this trial is taking place are available at: https://clinicaltrials.gov/ct2/show/NCT04162431
Lymphoma Action are not able to refer people to specific trials. If you are interested in taking part in this trial we recommend that you print the trial summary and discuss it with your medical team. They can advise you on whether you might be eligible for the trial and how you can take part based on your individual circumstances.